Sangel Capital Management Co., Ltd. is a venture capital investment firm established in 2010 in Shengzhen. Sangle Capital provides venture capital and business finance to support high-tech enterprises in China and western countries. The company seeks to invest innovative emerging-market enterprises in sectors including: biomedicine, medical devices, healthcare and bio-tech.
Sangel Capital has set Sage-Angel incubator and Sangel funds and been managing more than 50 projects. In July, 2015, Sangle Capital Management Co., Ltd. established its first international subsidiary—Sangel Capital Corp. (US) in Chicago, USA. This year, Sangel Capital Management Co., Ltd. won "China Outstanding Venture Capital Institution in Next Generation Award".
Shenzhen Beijing Shanghai Chicago
A Personalized Biomedical Technology
Biomedicine in China increased by 100 times in recent 15 years.
Unique research incubator and investment platform.
Valley Life Sciences Institute of Life in cooperat
We are not only concerned about the success of "innovation", more concerned about the "business" of success!
Professional high-tech equity investment platform.
The main concern: life sciences resources, biologi
Business operations based on the powerful ability of M-type investment patterns.
Relying on the drivi
Asset management services platform commissioned commissioned investment.
Customer demand, the objecti